Holders · period archive

IOVA · Iovance Biotherapeutics Inc.

Q2 2024 13F holders among managers we track latest ownership dossier

Ticker: IOVA
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares